News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
APPLY TODAY to The Innovative Molecular Analysis Technologies (IMAT) Program – National Cancer Institute
Photo from National Cancer Institute/Twitter
Aug 23, 2023, 14:38

APPLY TODAY to The Innovative Molecular Analysis Technologies (IMAT) Program – National Cancer Institute

National Cancer Institute shared on Twitter:

“APPLY TODAY: The Innovative Molecular Analysis Technologies (IMAT) Program is aimed at the development and integration of novel and emerging technologies in the support of Cancer Research, diagnosis, and treatment.”

For details click here.
Source: National Cancer Institute/Twitter

cancer Cancer research National Cancer Institute OncoDaily Oncology The Innovative Molecular Analysis Technologies
Special Coverage
Blog
Nov 2, 2024, 21:41
Abstract submission open for the AACR Annual Meeting 2025
Insight
Nov 2, 2024, 21:32
Shushan Hovsepyan: Are we overestimating the true benefits of cancer drugs?
Blog
Nov 2, 2024, 21:31
The ACHO Defying Cancer Award competition is open - Conquer Cancer, the ASCO Foundation
Insight
Nov 2, 2024, 21:28
Yan Leyfman: Inavolisib with palbociclib–fulvestrant for PIK3CA-mutated, HR+, HER2- breast cancer
Blog
Nov 2, 2024, 21:25
SIOPE and CCI-E Children's Rights Day event
Blog
Nov 2, 2024, 21:22
Nikolas Politis during his fellowship at the Champalimaud Clinical Centre - European School of Oncology
Blog
Nov 2, 2024, 21:19
Yin Ling Woo: A big boost for the third pillar of cervical cancer elimination
Blog
Nov 2, 2024, 21:18
Aachal Bajaj: Be so passionate about what you do that work doesn’t feel like work
Insight
Nov 2, 2024, 21:09
Equality, Diversity, and Inclusion in IJGC - European Society of Gynaecological Oncology
Insight
Nov 2, 2024, 21:06
Sabine Brookman-May: Are pre-treatment biopsies the way to go in mUC?
Insight
Nov 2, 2024, 20:53
Anand Patel: Therapy-related myeloid neoplasms review by Sangeetha Venugopal and Amy DeZern
Insight
Nov 2, 2024, 20:51
Daniel Shapiro: Our editorial regarding perioperative trials in RCC